MYCN and neuroblastoma: In earlier studies, Rasmuson et al. demonstrated that exogenous PGE2 enhanced viability of MYCN-amplified SK-N-BE(2) neuroblastoma cells, suggesting that PGE2 is involved in neuroblastoma cell viability independent of amplification of MYCN [4].